Tempest Therapeutics receives Nasdaq notice for annual meeting compliance By Investing.com
SWI Editorial Staff2026-01-09T19:44:27-08:00Tempest Therapeutics receives Nasdaq notice for annual meeting compliance
Tempest Therapeutics receives Nasdaq notice for annual meeting compliance
Simply Wall St 6 min read The recent shift in Bristol Myers Squibb’s fair value estimate from US$53.55 to US$56.26 per share reflects analysts weighing improving sentiment toward large drugmakers ...
Ethereum is becoming the institutional altcoin of choice, and timing matters, Ethereum price prediction now targets a pivotal 2026.
SharpLink Gaming recently deployed US$170 million worth of Ethereum to the Linea layer-2 network as part of a multi‑year effort to enhance on-chain yields from its crypto treasury. As the ...
Jenn Levy to head up unscripted for Amazon MGM Studios Former Netflix and NBCU unscripted exec Jenn Levy is heading to Amazon MGM Studios, in the role of head ...
The pill version of popular weight-loss drug Wegovy became available in the U.S. on Monday, offering patients a daily oral option to the weekly injectable drug. WASHINGTON — Novo Nordisk's ...
New York, Jan 9, 2026, 16:05 EST — After-hours Apple shares closed up 0.13% at $259.37, ending a seven-session losing streak Evercore lifted its Apple target to $330 and raised ...
LINCOLN, Neb. (WOWT) - Nebraska state senators wrapped up their first week of the second session on Friday, filing dozens more pieces of legislation. Lawmakers have 10 days to file ...
Bleichroeder Acquisition Corp. II closes $287.5 million IPO on NASDAQ
Drew Bohan, the California Energy Commission executive director, talks expediting renewable energy permits.